These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients. Rezailashkajani M; Roshandel D; Shafaee S; Zali MR Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):499-506. PubMed ID: 17489061 [TBL] [Abstract][Full Text] [Related]
27. [Indication for conservative therapy of reflux esophagitis (author's transl)]. Ottenjann R Langenbecks Arch Chir; 1978 Nov; 347():285-8. PubMed ID: 732429 [TBL] [Abstract][Full Text] [Related]
28. Comparative study of Riflux Forte and Riflux in cases of reflux oesophagitis. Chandra MA; Gandhi IS Br J Clin Pract; 1989 Apr; 43(4):144-7. PubMed ID: 2590624 [TBL] [Abstract][Full Text] [Related]
29. [Regurgitation esophagitis treated with Gaviscon]. Jakobsen BM; Amdrup E Nord Med; 1968 Sep; 80(38):1243-5. PubMed ID: 4301892 [No Abstract] [Full Text] [Related]
31. [Conservative management of gastroesophageal reflux and reflux esophagitis]. Fahrländer H Leber Magen Darm; 1972 Feb; 2(2):54-5. PubMed ID: 5073413 [No Abstract] [Full Text] [Related]
32. [Current principles of antacid therapy]. Grebenev AL; Sheptulin AA Klin Med (Mosk); 1993; 71(3):12-5. PubMed ID: 8015207 [No Abstract] [Full Text] [Related]
33. Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic-gland type: A retrospective, matched case-control study. Hayasaka J; Hoteya S; Takazawa Y; Kikuchi D; Araki A J Gastroenterol Hepatol; 2024 Aug; 39(8):1580-1585. PubMed ID: 38641971 [TBL] [Abstract][Full Text] [Related]
34. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis. Earnest DL; Dorsch E; Jones J; Jennings DE; Greski-Rose PA Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerance of Algicon in patients with reflux oesophagitis. Lancaster Smith MJ; Miller JP; Whorwell PJ Br J Clin Pract Suppl; 1989 Feb; 66():38-42; discussion 61-4. PubMed ID: 2511921 [No Abstract] [Full Text] [Related]
36. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial. McCallum RW; Fink SM; Winnan GR; Avella J; Callachan C Am J Gastroenterol; 1984 Mar; 79(3):165-72. PubMed ID: 6367434 [TBL] [Abstract][Full Text] [Related]
37. [Medical treatment of gastroesophageal reflux in adults]. Cadiot G Ann Gastroenterol Hepatol (Paris); 1996; 32(2):100-2. PubMed ID: 8737506 [No Abstract] [Full Text] [Related]
38. Effects of Algicon on the ultrastructure of the mucosa of subjects with reflux oesophagitis. Trabucchi E; Foschi D; Radaelli E; Callioni F; Montorsi W Br J Clin Pract Suppl; 1989 Feb; 66():43-7; discussion 61-4. PubMed ID: 2511922 [No Abstract] [Full Text] [Related]
39. [A comparative evaluation of the antacid properties of the preparations Maalox and Almagel]. Grebenev AL; Sheptulin AA; Okhlobystin AV Ter Arkh; 1994; 66(8):44-7. PubMed ID: 7985154 [TBL] [Abstract][Full Text] [Related]
40. [Effect of elevated head position in bed in therapy of gastroesophageal reflux]. Pollmann H; Zillessen E; Pohl J; Rosemeyer D; Abucar A; Armbrecht U; Bornhofen B; Herz R Z Gastroenterol; 1996 Jun; 34 Suppl 2():93-9. PubMed ID: 8767437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]